2022. Development of Solid Lipid Nanoparticles with Letrozole for Breast Cancer Treatment: in-vitro and in-vivo evaluation. Journal of Pharmaceutical Negative Results. (Oct. 2022), 1186–1194. DOI:https://doi.org/10.47750/pnr.2022.13.S06.156.